Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunityJ. David Peske, Víctor H. Engelhard|Nature Communications|2015Cited by 210
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancersJiaxin Ge, Steve Lu, X. Li et al.|Nature Cancer|2025Cited by 1
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Nour Sabiha Naji et al.|Research Square|2025Cited by 0